Ondertussen zijn de heren al aan het cashen.
https://www.google.be/amp/s/www.forbes. ... e-ipo/amp/
Peter Thiel’s secretive Palantir surges 38% in debut, valuation at nearly $22B
By Associated Press
September 30, 2020 | 1:22pm
Shares of Palantir Technologies Inc PLTR.N, the U.S. data analytics firm known for its work with the Central Intelligence Agency and other government bodies, jumped 38% in their market debut on Wednesday, valuing the company at nearly $22 billion.
Its shares traded at $10 apiece, compared with a reference price of $7.25 per share set by the New York Stock Exchange on Tuesday.
The listing is a landmark moment for Palantir and puts an end to years of speculation about when the company, co-founded by billionaire Peter Thiel in 2003, would ultimately go public and how much would it actually be worth.
Denver, Colorado-based Palantir is going public at a time of strong investor demand for new stocks, particularly of technology companies that promise rapid growth.
The company, led by CEO Alex Karp, has seen strong demand for its services, with revenue rising almost 50% to $481.2 million in the first six months of 2020 from the comparable period a year earlier.
However, it has yet to turn a profit in its 17 years of existence, posting a net loss of $164.7 million in the same period, down from a loss of $280.5 million a year earlier.
Laatste artikelen op Beursig.com
Hey guys, don't miss our @welt Podcast. We debate Palantir. Stock looks attractive but comes w/high pol risk. In H1'20 54% of revenue from govt clients. Palantir's high-touch model can’t scale as seamlessly as other Software as a Service stocks. MUST HEAR! https://t.co/hlGyChCo2M?amp=1
19:32 (03/11) - Bron: Reuters
The British government is in talks with U.S. data analytics company Palantir Technologies Inc in an attempt to strengthen its test-and-trace program for COVID-19, the Financial Times reported on Tuesday. Officials have been in talks with the tech company about using its Foundry software to manage sensitive contact tracing data, the FT reported, citing people familiar with the matter.
UK Prime Minister Boris Johnson promised a "world-beating" national test-and-trace system earlier this year, whereby people with COVID-19 symptoms get tested and the contacts of positive cases are asked to self-isolate. But the scheme has disappointed and the government's scientific advisory body said last month its impact on virus transmission was marginal.
Under the contract being discussed, the new modeling will potentially allow to track the spread of the disease through particular sectors or parts of the country, according to the FT report. Palantir and Britain's Health Department did not immediately respond to Reuters' requests for comment.
Alex Karb heeft de ambitie om het belangrijkste software bedrijf ter wereld te worden. In de prospectus staat ook het volgende: "Palantir says its goal is to become the 'default operating system' of the U.S. government." Ik denk dat de overheden uit het Westen binnen 5 à 10 jaar niet meer zonder Palantir kunnen.
(12/11) - Bron: Reuters
** Palantir Technologies shares up 2.5% at $16.36 premarket as data analytics firm preps inaugural report due Thurs after the bell, following its highly anticipated public debut
** PLTR, known for its secretive work with the CIA and other government groups, has seen its stock surge nearly 60% this month; Shares now well above $10 opening price since direct NYSE listing on Sept 30
** Last week, the UK government was reportedly in talks with PLTR in attempt to strengthen its test-and-trace program for COVID-19
** PLTR projected Q3 rev of $278-$280 mln, representing 46%-47% yr/yr growth, and non-GAAP operating income of $6-$8 mln (excluding stock-based compensation, related payroll tax expenses and ~$54 mln one-time expenses related to direct listing)
** For FY 2020, co said expects rev of $1.05-$1.06 bln with non-GAAP operating income of $62-$72 mln
** Of the 6 brokerages currently covering PLTR, 1 rates strong buy', 1 has 'buy' recommendation and the rest are neutral; median PT is $11 (Refinitiv data)
** When initiating coverage last month, Wall Street analysts highlighted large market opportunity for PLTR, but pointed to customer concentration and financial visibility among the issues keeping most of them on the sidelines
The stock fell more than 3% in extended trading after plunging 8.7% during the regular trading day.
Here are the key numbers:
Earnings: Loss of 94 cents per share vs loss of 24 cents a year earlier.
Revenue: $289.4 million vs $279.4 million expected, according to analysts polled by Refinitiv.
For the third quarter, the company reported an operating loss of $847.8 million due to an $847 charge for stock-based compensation.
Palantir raised its full-year revenue guidance to between $1.07 billion and $1.072 billion, which would represent 44% growth from a year earlier. The company previously said sales for the year would reach $1.06 billion. Adjusted operating income in 2020 is expected to be between $130 million and $136 million.
Co-founded in 2003 by tech investors Peter Thiel and Joe Lonsdale, CEO Alex Karp and others, Palantir provides data analytics software and services to government agencies, including the Defense Department, the U.S. Food and Drug Administration and the intelligence community. It also sells to companies like aircraft manufacturer Airbus and energy producer BP.
Palantir’s stock opened at $10 in its direct listing on Sept. 30, and has since climbed 46% to close at $14.58 on Thursday. Investors are paying close attention to the company’s customer base, which was limited to 125 in the first half of 2020. As the company focuses more on software and less on services, it’s trying to make it easier for clients to start using the product so it can expand its reach and bring down sales costs.
“Our customer concentration is decreasing,” the company said in the release. Palantir said that 61% of its revenue for the first nine months of the year came from its top 20 customers, down from 68% over the same stretch in 2019.
The company also said that new contracts in third quarter included a $91 million deal with the U.S. Army, a $36 million contract with the National Institutes of Health $36 million and a $300 million renewal with an aerospace customer.
Company executives will host a conference call to discuss results at 5 p.m. ET.